Summary of COVID-19 ensifentrine studies

1. MacDonald-Berko et al., A Single-center, Pilot, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ensifentrine in the Recovery of Hospitalized Patients With COVID-19

45 patient ensifentrine late treatment RCT: 150% higher mortality (p=1) and 150% worse recovery (p=1).
RCT 45 hospitalized COVID-19 patients showing no significant difference with ensifentrine treatment.
Apr 2021, NCT04527471, https://clinicaltrials.gov/study/NCT04527471, https://c19p.org/macdonaldberko